Real-time enrollment status for this solid tumors harboring met amplification clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:39 AM UTC
| NCT Number | NCT07196644 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors Harboring MET Amplification |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 17 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | July 10, 2026 (3 days ago) |
As of July 13, 2026: Clinical trial NCT07196644 is currently recruiting participants. This clinical trial study for solid tumors harboring met amplification is actively seeking new participants at 17 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07196644 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07196644 was last updated 3 days ago (July 10, 2026). HelloStudys verifies this status automatically.